Wuhan plov Biotechnology Co., Ltd. was established in 2019. From the perspective of strategic development, the board of directors of the company decided to respond to the call to build a national industrial base and move the headquarters of the company to Wuhan biomedical park. At the same time, taking advantage of the park's policy advantages, the company carries out industry research cooperation and introduces foreign investment. The company's main production base is located in Xianning, covering an area of 3000 mu,. The company has cooperated with Wuhan University, Huazhong University of science and technology, Wuhan University of engineering and other relevant experts and professors to form a group of technical expert teams, which are specially responsible for the optimization of steroid synthesis process and the development of green production process, so as to ensure that plov's production technology is at the international leading level.